Evidence map›Paper›PMID 29228556›Full record

ArticleOncotarget2017

Tao Li, Min Shan, Jing He, Xiaolan Wang, Shaohui Wang, Mingxing Tian, Jingjing Qi, Tingrong Luo, Yonghong Shi, Chan Ding and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Acquisition and Spread of Antimicrobial Resistance: AInternational journal of molecular sciences · 2021
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Tao LiShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Min ShanShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Jing HeShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Xiaolan WangShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Shaohui WangShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Mingxing TianShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Jingjing QiShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Tingrong LuoCollege of Animal Science and Technology, Guangxi University, Guangxi, China.
Yonghong ShiShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Chan DingShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Shengqing YuShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Shanghai Veterinary Research Institute · CNChinese Academy of Agricultural Sciences · CNGuangxi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on its important role in last-line therapeutics against multidrug-resistant bacteria, tigecycline has been increasingly important in treating infections. However, mounting reports on tigecycline-resistant bacterial strains isolated from different sources are of concern, and molecular mechanisms regarding tigecycline resistance are poorly understood.

Indexed as

M949_0459 geneMICPathology SectionresistanceRiemerella anatipestifertigecycline

Identifiers

PMID29228556
PMCPMC5722508
OpenAlexW2741950265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.